Form4.ai tracks every SEC insider trade in real time. See every URGN insider filing with a free account — no card.
See every URGN insider filing — free account, no card.
Free accountUroGen Pharma Ltd. (URGN) has 4 SEC Form 4 insider filings on record in the last 90 days. No insider purchases were filed — 1 sales totalling $2.9M. Most recent filing: Oct. 9, 2026.
Open-market value, last 90 days
Form 4 filings by type, last 90 days
| Date | Insider | Trade | Value | Price since buy |
|---|---|---|---|---|
| Oct 9, 2026 SEC filing | Degnan Chris Chief Financial Officer | Vest & sell-to-cover | +2,281 sh | — |
| Sep 9, 2026 SEC filing | Schoenberg Mark Chief Medical Officer | Vest & sell-to-cover | +796 sh | — |
| Sep 9, 2026 SEC filing | Smith Jason Drew General Counsel | Vest & sell-to-cover | +1,815 sh | — |
Create a free account to see all 4 URGN filings from the last 90 days. No card needed.
Create free accountWant URGN insider buys the moment they're filed, with Telegram alerts? Try Pro free for 7 days
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.